AR080294A1 - Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia - Google Patents

Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia

Info

Publication number
AR080294A1
AR080294A1 ARP110100555A ARP110100555A AR080294A1 AR 080294 A1 AR080294 A1 AR 080294A1 AR P110100555 A ARP110100555 A AR P110100555A AR P110100555 A ARP110100555 A AR P110100555A AR 080294 A1 AR080294 A1 AR 080294A1
Authority
AR
Argentina
Prior art keywords
solubility
administration
magnolia
improve
active compounds
Prior art date
Application number
ARP110100555A
Other languages
English (en)
Inventor
Subramanyam Ravi
Fei Lin
Guofeng Xu
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR080294A1 publication Critical patent/AR080294A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

Métodos para el mejoramiento de la solubilidad y administracion de uno o más de los ingredientes activos hallados en el extracto de magnolia o uno de sus análogos sintéticos, en una composicion de uso oral. Reivindicacion 1: Una composicion de uso oral caracterizada porque incluye entre 0,05 y 10% en peso de propilenglicol; entre 0,05 y 5% en peso de al menos uno o más de los ingredientes activos hallados en el extracto de magnolia o uno de sus análogos sintéticos, donde al menos uno de los uno o más ingredientes activos es seleccionado a partir del grupo constituido por extracto de magnolia, magnolol, honokiol, tetrahidromagnolol, tetrahidrohonokiol (propilhonokiol), 5,5'-di-n-butil-bifenil-2,2'-diol y una combinacion de dos o más de ellos; y un vehículo oralmente aceptable.
ARP110100555A 2010-02-24 2011-02-24 Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia AR080294A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30766410P 2010-02-24 2010-02-24

Publications (1)

Publication Number Publication Date
AR080294A1 true AR080294A1 (es) 2012-03-28

Family

ID=43768879

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100555A AR080294A1 (es) 2010-02-24 2011-02-24 Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia

Country Status (16)

Country Link
US (1) US9801940B2 (es)
EP (1) EP2523676B1 (es)
JP (1) JP5665888B2 (es)
CN (1) CN102762219B (es)
AR (1) AR080294A1 (es)
AU (1) AU2011220789B2 (es)
BR (1) BR112012019997A2 (es)
CA (1) CA2788423A1 (es)
CO (1) CO6592076A2 (es)
MX (1) MX2012009139A (es)
PH (1) PH12012501620A1 (es)
RU (2) RU2015114797A (es)
SG (1) SG183117A1 (es)
TW (1) TWI422382B (es)
WO (1) WO2011106492A1 (es)
ZA (1) ZA201206068B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI459957B (zh) * 2010-02-24 2014-11-11 美國棕欖公司 口腔保健組成物
PH12013501147A1 (en) 2010-12-21 2016-06-03 Colgate Palmolive Co Halogenated biphenols as antibacterial agents
BR112014005439A2 (pt) * 2011-09-08 2017-04-04 Colgate Palmolive Co composições de higiene bucal
EP2793812A1 (en) * 2011-12-02 2014-10-29 Colgate-Palmolive Company Oral care compositions comprising n-butyl magnolol and isobutyl magnolol
MX340815B (es) * 2011-12-02 2016-07-27 Colgate Palmolive Co Composicion de cuidado bucal que comprende isobutil magnolol.
CN104023698B (zh) * 2011-12-15 2016-10-05 高露洁-棕榄公司 溶解的厚朴酚类似物
CA2857648A1 (en) * 2011-12-15 2013-06-20 Colgate-Palmolive Company Oral care or cleanser composition comprising solubilized magnolol analogs and ppg-1- peg-9 lauryl glycol ether
BR112014014207B1 (pt) * 2011-12-15 2018-02-14 Colgate-Palmolive Company Composição compreendendo análogos de magnolol solubilizados
RU2014129908A (ru) 2011-12-20 2016-02-10 Колгейт-Палмолив Компани Способы получения аналогов магнолола
US9000231B2 (en) 2011-12-20 2015-04-07 Colgate-Palmolive Company Processes for making magnolol and derivatives thereof
JP2015508817A (ja) * 2012-03-02 2015-03-23 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ オーラル・ケア組成物
EP2948220B1 (en) 2013-01-23 2018-07-04 Colgate-Palmolive Company Processes for making magnolol derivatives
WO2014131191A1 (en) * 2013-03-01 2014-09-04 Johnson & Johnson Consumer Companies, Inc. A composition containing honokiol and/or magnolol and uses thereof
MX388490B (es) * 2015-07-14 2025-03-20 Wrigley W M Jun Co Extracto de corteza de magnolia como ligando hidrofobico para remocion preferencial de bacterias gram negativas de la cavidad oral.
GB201907225D0 (en) * 2019-05-22 2019-07-03 Cosmetic Warriors Ltd Composition
KR102465358B1 (ko) * 2021-11-05 2022-11-11 주식회사 엑티브온 마그놀올, 호노키올, 또는 이의 조합을 포함하는 피부 외용제용 보존제 및 이를 포함하는 화장료 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0176015B1 (ko) 1996-03-26 1999-03-20 서치영 치주질환 예방 및 치료제 조성물
WO2001082922A1 (en) * 2000-04-27 2001-11-08 The Procter & Gamble Company Oral compositions comprising polyphenol herbal extracts
US6500409B1 (en) * 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
US6544409B2 (en) 2001-05-16 2003-04-08 Petroleo Brasileiro S.A. - Petrobras Process for the catalytic oxidation of sulfur, nitrogen and unsaturated compounds from hydrocarbon streams
CN1147286C (zh) * 2001-07-18 2004-04-28 广州美晨股份有限公司 一种中药牙膏
US7347985B2 (en) * 2002-06-25 2008-03-25 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract
US7632525B2 (en) * 2002-06-25 2009-12-15 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents
CN1662220A (zh) * 2002-06-25 2005-08-31 Wm.雷格利Jr.公司 含有肉桂醛的口气清新和口腔清洁产品
US20060127329A1 (en) 2004-12-10 2006-06-15 Colgate-Palmolive Company Tartar control oral care composition containing extract of magnolia
US8900644B2 (en) * 2004-12-22 2014-12-02 Colgate-Palmolive Company Oral care compositions containing compounds from magnolia and hops extracts
US20060140885A1 (en) 2004-12-29 2006-06-29 Abdul Gaffar Method of reducing oral tissue inflammation using magnolia extract
US8071077B2 (en) * 2004-12-29 2011-12-06 Colgate-Palmolive Company Oral compositions containing biphenol antibacterial compounds
CN101132806A (zh) * 2004-12-29 2008-02-27 高露洁-棕榄公司 使用木兰提取物减少口腔组织炎症的方法
US7608741B2 (en) * 2005-05-30 2009-10-27 Korea Institute Of Oriental Medicine Mass separation method of magnolol from Magnoliae cortex radix
WO2008006582A1 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
WO2009045952A1 (en) 2007-10-01 2009-04-09 Colgate-Palmolive Company Oral compositions containing botanical extracts

Also Published As

Publication number Publication date
PH12012501620A1 (en) 2012-10-22
RU2012140474A (ru) 2014-03-27
RU2015114797A (ru) 2015-09-20
ZA201206068B (en) 2015-04-29
US20120294812A1 (en) 2012-11-22
EP2523676B1 (en) 2016-04-20
BR112012019997A2 (pt) 2019-09-24
CN102762219B (zh) 2016-05-04
CO6592076A2 (es) 2013-01-02
CN102762219A (zh) 2012-10-31
TWI422382B (zh) 2014-01-11
AU2011220789A1 (en) 2012-08-23
SG183117A1 (en) 2012-09-27
WO2011106492A1 (en) 2011-09-01
US9801940B2 (en) 2017-10-31
RU2552322C2 (ru) 2015-06-10
EP2523676A1 (en) 2012-11-21
TW201204376A (en) 2012-02-01
JP5665888B2 (ja) 2015-02-04
JP2013520517A (ja) 2013-06-06
AU2011220789B2 (en) 2013-07-18
MX2012009139A (es) 2012-09-21
CA2788423A1 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
AR080294A1 (es) Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia
AR080295A1 (es) Composiciones para el cuidado bucal y metodos de tratamiento
AR093244A1 (es) Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2
GT201400136A (es) Compuestos y métodos de benzaldehído substituído para su uso en incrementar la oxigenación de los tejidos
CU20140068A7 (es) Triazolopiridinas sustituidas
AR082686A1 (es) Adyuvantes de vacuna que direccionan a los adyuvantes de anticuerpos directamente hacia las celulas presentadoras de antigenos
CU20120171A7 (es) Triazolopiridinas sustituidas
CL2008002228A1 (es) Compuestos derivados de imidazopiridinonas, agonista de tlr7; procedimiento de preparacion; compuestos intermediarios; composiicon farmaceutica que los comprende; y uso en infecciones virales, bacterianas y fungicas.
CU20110239A7 (es) Composición farmacéutica para la anticoncepción de emergencia
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
ECSP12012031A (es) Composición farmacéutica que comprende oligopéptidos
BR112014002594A2 (pt) uso de diésteres de isossorbida como espessantes
AR085042A1 (es) Composiciones de cuidado oral con extracto de magnolia
EA201490222A1 (ru) Комбинированные составы на основе дарунавира
PE20150630A1 (es) Composicion de compuesto bajo en agua para juntas de tipo secado y metodo para elaborar el compuesto
MX338801B (es) Composiciones de cuidado oral.
AR083769A1 (es) Formulaciones orales que comprenden polietilenglicol
MX2017009306A (es) Vacuna contra la fiebre aftosa.
BR112014002570A2 (pt) uso de monoésteres de isossorbida como espessantes
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
CR11755A (es) Dronedarona para la prevencion de la cardioversion
ES2648190T3 (es) Compuestos para su uso en el tratamiento de la filariasis
BR112015014180A2 (pt) composições de gel
CL2011003355A1 (es) Compuestos derivados de alcoxi-carbonil-amino-alquinil-adenosina ; composición farmacéutica que los comprende; uso del compuesto en la preparación de un medicamento útil para tratar enfermedades autoinmunes, inflamatorias, alérgicas, infecciosas entre otras.
CL2014000754A1 (es) Compuestos aldehidos cicloalcanicos; procedimiento de preparacion; composicion que los comprende ademas de al menos otra sustancia odorante; su uso en composiciones de perfumeria, composiciones topicas cosmeticas o tambien productos de limpieza.

Legal Events

Date Code Title Description
FB Suspension of granting procedure